Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Canducci

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|January 9, 2010
Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravirFilippo Canducci, Maria Chiara Marinozzi, Michela Sampaolo, et al.
Scientific Reports|July 8, 2016
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammationDiego Saita, Roberto Ferrarese, Chiara Foglieni, et al.
Retrovirology|January 17, 2009
Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjectsFilippo Canducci, Maria Chiara Marinozzi, Michela Sampaolo, et al.
Journal of Virology|March 28, 2008
Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane proteinFilippo Pacciarini, Silvia Ghezzi, Filippo Canducci, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2019
Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetesChiara Sorini, Ilaria Cosorich, Marta Lo Conte, et al.
The New Microbiologica|February 5, 2010
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV)Roberto Burioni, Filippo Canducci, Nicasio Mancini, et al.
Plos One|June 6, 2018
Rhodanine derivatives as potent anti-HIV and anti-HSV microbicidesCristina Tintori, Giulia Iovenitti, Elisa Rita Ceresola, et al.
AIDS (London, England)|February 16, 2010
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experienceSilvia Nozza, Laura Galli, Francesca Visco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2014
Immunological recovery after 24 weeks of antiretroviral therapy in patients with X4 virus during primary HIV infectionSilvia Nozza, Angela R Pignataro, Laura Galli, et al.
The Lancet. Infectious Diseases|December 12, 2022
TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trialMan-Fung Yuen, Rozalina Balabanska, Emmanuelle Cottreel, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|January 9, 2010
Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravirFilippo Canducci, Maria Chiara Marinozzi, Michela Sampaolo, et al.
Scientific Reports|July 8, 2016
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammationDiego Saita, Roberto Ferrarese, Chiara Foglieni, et al.
Retrovirology|January 17, 2009
Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjectsFilippo Canducci, Maria Chiara Marinozzi, Michela Sampaolo, et al.
Journal of Virology|March 28, 2008
Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane proteinFilippo Pacciarini, Silvia Ghezzi, Filippo Canducci, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2019
Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetesChiara Sorini, Ilaria Cosorich, Marta Lo Conte, et al.
The New Microbiologica|February 5, 2010
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV)Roberto Burioni, Filippo Canducci, Nicasio Mancini, et al.
Plos One|June 6, 2018
Rhodanine derivatives as potent anti-HIV and anti-HSV microbicidesCristina Tintori, Giulia Iovenitti, Elisa Rita Ceresola, et al.
AIDS (London, England)|February 16, 2010
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experienceSilvia Nozza, Laura Galli, Francesca Visco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2014
Immunological recovery after 24 weeks of antiretroviral therapy in patients with X4 virus during primary HIV infectionSilvia Nozza, Angela R Pignataro, Laura Galli, et al.
The Lancet. Infectious Diseases|December 12, 2022
TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trialMan-Fung Yuen, Rozalina Balabanska, Emmanuelle Cottreel, et al.
Pageof 7